Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Joanne M. Carson"'
Autor:
Joanne M. Carson, Sebastiano Barbieri, Evan Cunningham, Eric Mao, Marc van derValk, Jürgen K. Rockstroh, Margaret Hellard, Arthur Kim, Sanjay Bhagani, Jordan J. Feld, Ed Gane, Maria C. Thurnheer, Julie Bruneau, Elise Tu, Gregory J. Dore, Gail V. Matthews, Marianne Martinello, the REACT study group
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 9, Pp n/a-n/a (2023)
Abstract Introduction Exploration of sexual and drug use behaviours following treatment for recent hepatitis C virus (HCV) is limited. This analysis modelled behavioural trajectories following treatment for recent HCV and assessed reinfection. Method
Externí odkaz:
https://doaj.org/article/b3262514476c4462adada919df457c2f
Autor:
Jasmine Yee, Joanne M. Carson, Behzad Hajarizadeh, Joshua Hanson, James O’Beirne, David Iser, Phillip Read, Anne Balcomb, Joseph S. Doyle, Jane Davies, Marianne Martinello, Philiipa Marks, Gregory J. Dore, Gail V. Matthews, the REACH‐C Study Group
Publikováno v:
Hepatology Communications, Vol 6, Iss 3, Pp 496-512 (2022)
Australia was one of the first countries with unrestricted access to government subsidized direct‐acting antiviral (DAA) therapy for adults with chronic hepatitis C virus. This study assessed real‐world DAA treatment outcomes across a diverse ran
Externí odkaz:
https://doaj.org/article/6ac5d77488804b4bb5a968076b6a8270
Autor:
Kris Hage, Marita van de Kerkhof, Anders Boyd, Joanne M. Carson, Astrid M. Newsum, Amy Matser, Marc van der Valk, Kees Brinkman, Joop E. Arends, Fanny N. Lauw, Bart J. A. Rijnders, Arne van Eeden, Marianne Martinello, Gail V. Matthews, Janke Schinkel, Maria Prins
Publikováno v:
Pathogens, Vol 12, Iss 10, p 1248 (2023)
We assessed the predictive capacity of the HCV-MOSAIC risk score, originally developed for primary early HCV infection, as a screening tool for HCV reinfection in 103 men who have sex with men (MSM) with HIV using data from the MOSAIC cohort, includi
Externí odkaz:
https://doaj.org/article/9d5ba0e6445c403f8af77efbeb5f24f9
Publikováno v:
Clinical Infectious Diseases.
Background People experiencing homelessness are disproportionately affected by hepatitis C virus (HCV) infection compared with housed populations. Surveillance for HCV reinfection after successful treatment is a critical step in the care cascade, but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e994d80d467b7938faa62c47a9365fdf
https://doi.org/10.1093/cid/ciad127
https://doi.org/10.1093/cid/ciad127
Autor:
Joanne M, Carson, Behzad, Hajarizadeh, Josh, Hanson, James, O'Beirne, David, Iser, Phillip, Read, Anne, Balcomb, Jane, Davies, Joseph S, Doyle, Jasmine, Yee, Marianne, Martinello, Philippa, Marks, Gail V, Matthews, Gregory J, Dore
Publikováno v:
Journal of Viral Hepatitis. 29:661-676
Virological failure occurs in a small proportion of people treated for hepatitis C virus (HCV) with direct-acting antiviral (DAA) therapies. This study assessed retreatment for virological failure in a large real-world cohort. REACH-C is an Australia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21af2f8ac53af1468613c64ef0a146a1
https://doi.org/10.1111/jvh.13705
https://doi.org/10.1111/jvh.13705
Autor:
Joanne M, Carson, Gregory J, Dore, Andrew R, Lloyd, Jason, Grebely, Marianne, Byrne, Evan, Cunningham, Janaki, Amin, Peter, Vickerman, Natasha K, Martin, Carla, Treloar, Marianne, Martinello, Gail V, Matthews, Behzad, Hajarizadeh, Jodie, Anlezark
Publikováno v:
Clinical Infectious Diseases. 75:1809-1819
Background Injection drug use (IDU) following treatment for hepatitis C virus (HCV) infection may lead to reinfection, particularly if access to harm reduction services is suboptimal. This study assessed HCV reinfection risk following direct-acting a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::659397139af3d66ac320571543ab075b
https://doi.org/10.1093/cid/ciac246
https://doi.org/10.1093/cid/ciac246
Autor:
Joanne M. Carson, Gail V. Matthews, Anne Balcomb, Jane Davies, Marianne Martinello, Jasmine Yee, Joseph Doyle, Behzad Hajarizadeh, Gregory J. Dore, Joshua Hanson, James O'Beirne, D. Iser, Philiipa Marks, Phillip Read
Publikováno v:
Hepatology Communications. 6:496-512
Australia was one of the first countries with unrestricted access to government subsidized direct-acting antiviral (DAA) therapy for adults with chronic hepatitis C virus. This study assessed real-world DAA treatment outcomes across a diverse range o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff90d8b0843d4daea3e69be7a8e986bb
https://doi.org/10.1002/hep4.1826
https://doi.org/10.1002/hep4.1826
Publikováno v:
Journal of hepatology.
Population-level uptake of direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection, including retreatment, can be estimated through administrative pharmaceutical dispensation data. However, the reasons for retreatment are not ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca08773bda5feecee703eb325f19dd69
https://pubmed.ncbi.nlm.nih.gov/36152766
https://pubmed.ncbi.nlm.nih.gov/36152766
Publikováno v:
Journal of Hepatology. 78:1084
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd368837bbd7b2548a134789878321dc
https://doi.org/10.1016/j.jhep.2023.02.020
https://doi.org/10.1016/j.jhep.2023.02.020
Autor:
Gail V. Matthews, Samira Hosseini-Hooshyar, David R. Shaw, Joanne M. Carson, Cease study team, Jasmine Yee, David Baker, Joseph Doyle, Margaret Hellard, Gregory J. Dore, Mark Bloch, Phillip Read, Jeffrey J. Post, Kathy Petoumenos, Marianne Martinello, Robert Finlayson
Publikováno v:
AIDS. 34:1347-1358
Objective(s) To evaluate changes in injecting and sexual risk behaviours, and hepatitis C virus (HCV) reinfection incidence among people with HIV/HCV coinfection following unrestricted access to direct-acting antiviral therapy in Australia. Design Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff1c31bd5d947c90d17c7863b8919498
https://doi.org/10.1097/qad.0000000000002562
https://doi.org/10.1097/qad.0000000000002562